Our method synergistically halted cell division and induced cancer cell death, anti-angiogenesis, and TAM depletion in orthotopic patient-derived glioblastoma xenografts, which were consistent with the previously reported antitumor activities of the TK/GCV and CD/5-FC systems [8,9,14,23,38,48]. This evidence concerns the gene TKT and glioblastoma.